Videos / MRAs for heart failure update – New developments

expert
Cardiologist; Director, Heart Failure Unit, Department of Cardiac Rehabilitation, Concord Hospital; Head, Department of Cardiology, Ryde Hospital
0 hours
These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.
0 hours
These are activities that require reflection on feedback about your work.
0 hours
These are activities that use your work data to ensure quality results.
0 hours
These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.
0 hours
These are activities that require reflection on feedback about your work.
0 hours
These are activities that use your work data to ensure quality results.
Mineralocorticoid receptor antagonists (MRAs) are one of the four pillars of heart failure management – but are all MRAs the same? In this talk, cardiologist Professor Andrew Sindone discusses the important role MRAs have in treating heart failure and the differences between the different MRAs available. In particular, he will focus on the MRA, eplerenone and present the evidence that supports the recommendation that it be the first choice when prescribing an MRA to a patient with heart failure with reduced ejection fraction.

The Peptide Craze – What You Need to Know

Managing Acute Heart Failure After Discharge: A Practical Guide for GPs

Oral Contraceptives on the PBS – A Practical Guide for GPs

The Impact of PFAS & Other Endocrine Disrupting Chemicals on Fertility
Browse the latest videos from Healthed.